Stockscreener 앱 받기
339.03
0.47%
1.60
시장 영업 전:
338.05
-0.98
-0.29%
전일 마감가:
$337.43
열려 있는:
$336.67
하루 거래량:
1.80M
Relative Volume:
0.68
시가총액:
$129.97B
수익:
$25.27B
순이익/손실:
$3.34B
주가수익비율:
39.27
EPS:
8.6334
순현금흐름:
$4.57B
1주 성능:
+4.08%
1개월 성능:
+2.82%
6개월 성능:
-5.38%
1년 성능:
-9.92%
1일 변동 폭
$332.54
$340.00
1주일 범위
$330.16
$343.87
52주 변동 폭
$281.00
$396.86
스트라이커 Stock (SYK) Company Profile
명칭
Stryker Corp
전화
(269) 385-2600
주소
1941 STRYKER WAY, PORTAGE, MI
Compare SYK vs ABT, MDT, BSX, EW
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
SYK
Stryker Corp
|
339.03 | 129.09B | 25.27B | 3.34B | 4.57B | 8.6334 |
ABT
Abbott Laboratories
|
107.81 | 182.00B | 46.59B | 5.41B | 7.38B | 3.0938 |
MDT
Medtronic Plc
|
87.16 | 107.81B | 36.36B | 4.84B | 5.43B | 3.7261 |
BSX
Boston Scientific Corp
|
49.31 | 67.64B | 20.62B | 3.56B | 3.48B | 2.3847 |
EW
Edwards Lifesciences Corp
|
89.72 | 47.81B | 6.30B | 1.07B | 1.09B | 1.8406 |
스트라이커 Stock (SYK) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2026-04-13 | 개시 | Leerink Partners | Outperform |
| 2026-02-20 | 개시 | William Blair | Outperform |
| 2026-01-27 | 재개 | TD Cowen | Hold |
| 2026-01-06 | 업그레이드 | Raymond James | Mkt Perform → Outperform |
| 2025-12-19 | 업그레이드 | Citizens JMP | Mkt Perform → Mkt Outperform |
| 2025-09-18 | 개시 | Rothschild & Co Redburn | Neutral |
| 2025-02-26 | 재개 | Citigroup | Buy |
| 2024-12-02 | 업그레이드 | Morgan Stanley | Equal-Weight → Overweight |
| 2024-09-10 | 개시 | Wolfe Research | Outperform |
| 2024-05-30 | 개시 | Goldman | Neutral |
| 2024-05-22 | 업그레이드 | Needham | Hold → Buy |
| 2024-01-31 | 업그레이드 | Canaccord Genuity | Hold → Buy |
| 2023-10-20 | 개시 | ROTH MKM | Buy |
| 2023-09-05 | 업그레이드 | BofA Securities | Neutral → Buy |
| 2023-03-29 | 개시 | UBS | Neutral |
| 2023-01-25 | 개시 | KeyBanc Capital Markets | Sector Weight |
| 2023-01-09 | 업그레이드 | RBC Capital Mkts | Sector Perform → Outperform |
| 2022-11-01 | 다운그레이드 | Canaccord Genuity | Buy → Hold |
| 2022-10-18 | 개시 | Barclays | Overweight |
| 2022-10-12 | 개시 | Jefferies | Buy |
| 2022-07-28 | 업그레이드 | Edward Jones | Hold → Buy |
| 2022-07-21 | 다운그레이드 | Deutsche Bank | Buy → Hold |
| 2022-07-11 | 다운그레이드 | BofA Securities | Buy → Neutral |
| 2022-04-13 | 개시 | Truist | Hold |
| 2022-03-16 | 업그레이드 | Bernstein | Mkt Perform → Outperform |
| 2022-03-15 | 재개 | Evercore ISI | Outperform |
| 2022-03-02 | 재개 | BofA Securities | Buy |
| 2022-01-07 | 다운그레이드 | Morgan Stanley | Overweight → Equal-Weight |
| 2022-01-04 | 업그레이드 | Piper Sandler | Neutral → Overweight |
| 2021-12-10 | 개시 | RBC Capital Mkts | Sector Perform |
| 2021-12-07 | 개시 | Loop Capital | Buy |
| 2021-09-14 | 재개 | Raymond James | Mkt Perform |
| 2021-07-28 | 업그레이드 | Northland Capital | Market Perform → Outperform |
| 2021-06-01 | 업그레이드 | Evercore ISI | In-line → Outperform |
| 2021-05-25 | 개시 | Barclays | Underweight |
| 2020-10-06 | 개시 | Northland Capital | Market Perform |
| 2020-09-11 | 개시 | Wolfe Research | Peer Perform |
| 2020-04-13 | 다운그레이드 | Barclays | Equal Weight → Underweight |
| 2020-04-01 | 다운그레이드 | Goldman | Buy → Sell |
| 2020-03-05 | 개시 | Citigroup | Buy |
| 2020-02-13 | 개시 | Goldman | Buy |
| 2020-01-08 | 개시 | SunTrust | Hold |
| 2020-01-07 | 다운그레이드 | Piper Jaffray | Overweight → Neutral |
| 2020-01-07 | 다운그레이드 | Piper Sandler | Overweight → Neutral |
| 2019-12-30 | 재확인 | BTIG Research | Buy |
| 2019-11-05 | 다운그레이드 | Barclays | Overweight → Equal Weight |
| 2019-10-30 | 재확인 | BofA/Merrill | Buy |
| 2019-07-02 | 다운그레이드 | Evercore ISI | Outperform → In-line |
| 2019-01-30 | 재확인 | Canaccord Genuity | Buy |
| 2019-01-03 | 개시 | Deutsche Bank | Buy |
| 2019-01-02 | 업그레이드 | Evercore ISI | In-line → Outperform |
| 2018-10-16 | 개시 | Barclays | Overweight |
| 2018-08-16 | 개시 | BTIG Research | Buy |
| 2018-06-27 | 개시 | Bernstein | Mkt Perform |
| 2018-04-27 | 재확인 | Stifel | Buy |
모두보기
스트라이커 주식(SYK)의 최신 뉴스
Stryker (SYK) Launches Mako RPS To Bring Robotic Knee Surgery To More Surgeons - Yahoo Finance
UBS reiterates Stryker stock Buy rating with $400 price target - Investing.com
Ultrasonic Aspirator Market Size Projected to Reach USD 376.32 Million by 2035 | SNS Insider - GlobeNewswire Inc.
UBS reiterates Stryker stock Buy rating with $400 price target By Investing.com - Investing.com Canada
Stryker Corp (SYK) Financial Health: Profitability & Balance Sheet Analysis - TradingKey
Stryker Corp. stock outperforms competitors on strong trading day - MarketWatch
Lyle Stein's Top Picks: ExxonMobil, iShares MSCI South Korea ETF & Stryker - BNN Bloomberg
Exploring Analyst Estimates for Stryker (SYK) Q2 Earnings, Beyond Revenue and EPS - Yahoo Finance
Stryker's Q2 Results Likely to Reflect Recovery of Q1 Deferred Orders - Yahoo Finance
Stryker Corp (SYK) Cash Flow - TradingKey
Stryker Corp (SYK) Technical Analysis: Support, Resistance, Indicators & Moving Averages - TradingKey
Stryker stock trades near highs as orthopedic demand supports revenue growth - Ad-hoc-news.de
Stryker Corp (SYK) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey
SYK|Stryker Corp|Price:336.750|Chg%:+6.500 - TradingKey
SYK|Stryker Corp|Price:330.250|Chg%:+11.440 - TradingKey
Stryker Corp Stock (SYK) Moved Up by 3.15% on Jul 24: Facts Behind the Movement - TradingKey
Stryker Gains as Recovery Optimism Builds Ahead of Q2 Results - Moomoo
Stryker Corp Stock (SYK) Closed Up by 3.21% on Jul 23: Drivers Behind the Movement - TradingKey
Stryker Corp (SYK) Institutional Confidence - TradingKey
Stryker stock holds gains as medical device growth supports valuation - AD HOC NEWS
Stryker Corp (SYK) Shares Surge 3.1% -- What GF Score of 92 Tells Investors - GuruFocus
The Zacks Analyst Blog Highlights Qualcomm, Intuitive Surgical, Stryker, Frequency Electronics and Good Times Restaurants - Yahoo Finance
Stryker (SYK) Offers Attractive Valuations Amid Market Shifts - GuruFocus
Stryker stock trades steadily as medical device growth supports valuation - AD HOC NEWS
Boston Scientific Settles With Stryker In Spine Device IP Fight - Law360
Top Stock Reports for Qualcomm, Intuitive Surgical & Stryker - Yahoo Finance
Stryker Corp. stock underperforms Wednesday when compared to competitors - MarketWatch
Boston Scientific, Stryker Settle Surgical Device Patent Dispute - Bloomberg Law News
Stryker Corp. stock underperforms Tuesday when compared to competitors - MarketWatch
Stryker stock trades steadily as recent earnings and growth investments shape outlook - Ad-hoc-news.de
Stryker stock builds on earnings momentum after 16 July 2026 update - Ad-hoc-news.de
Stryker stock trades on its latest reported growth - ad-hoc-news.de
Mako Handheld Robotic Knee System Launch Might Change The Case For Investing In Stryker (SYK) - Yahoo Finance
Is Stryker Corp (SYK) a Bargain After 3.4% Drop? GF Value Says U - GuruFocus
Stryker Corp. stock underperforms Friday when compared to competitors - MarketWatch
Stryker Corp Stock (SYK) Moved Down by 3.42% on Jul 17: A Full Analysis - TradingKey
Stryker stock trades near highs as robotics and trauma growth support valuation - ad-hoc-news.de
Stryker Launches Mako RPS to Expand Robotic Knee Surgery Portfolio - The Globe and Mail
Stryker Corp (XTER:SYK) Stock Price, Trades & News - GuruFocus
Stryker (SYK) Launches Mako RPS Handheld Robot for Knee Replacem - GuruFocus
Stryker Shares Rise After Commercial Launch of Mako Robotic Power System - Moomoo
Stryker (SYK) Introduces Mako RPS for Total Knee Replacements - GuruFocus
Stryker launches Mako RPS handheld robotic knee system in U.S. - Investing.com
Stryker expands Mako robotics portfolio with full market release of Mako RPS - Finviz
Stryker expands Mako robotics portfolio with full market release of Mako RPS – Company Announcement - Financial Times
Stryker's quarterly earnings preview: What you need to know - MSN
Stryker Corp (SYK) Stock Down 6.2% -- Now Undervalued? GF Score: 92/100 - GuruFocus
Goldman Sachs Adjusts Price Target on Stryker to $339 From $363, Maintains Neutral Rating - Moomoo
Stryker Corp Stock (SYK) Moved Down by 5.49% on Jul 14: A Full Analysis - TradingKey
Fund Update: 43,404 STRYKER (SYK) shares added to Douglas Lane & Associates, LLC portfolio - Quiver Quantitative
Stryker Slides As Investors Reassess Cyberattack Recovery Ahead Of Q2 Results - Quiver Quantitative
스트라이커 (SYK) 재무 분석
매출
순이익
현금흐름
주당 순 이익
스트라이커 주식 (SYK) 내부자 거래
| 내부자 거래 | 관계 | 날짜 | 거래 | 비용 | #주식 | 가치 ($) | #주식 총계 |
|---|---|---|---|---|---|---|---|
| STRYKER RONDA E | Director |
May 26 '26 |
Sale |
312.23 |
310,000 |
96,792,669 |
1,924,880 |
1.44%
0.14%
자본화:
|
볼륨(24시간):